The pioneer for menschliche Mikrobiota invests in a flexible and transparent carrying case, which allows patients to better manage their work.

OTTAWA, Ontario, December 16, 2024–(BUSINESS FEED)–Biocodexa pioneer and pioneer in the field of innovative human microbiota in drug development, working with Kinaxis^® Inc. (TSX:KXS) aims to provide global support for end-to-end contract organization, modernization and optimization process. This investment will allow you to support Biocodex as a buyer, an environmental administration business and a wider range of applications in stores.

Biocodex is a French, in Familienbesitz befindliches Unternehmen, which is the pioneer of microbiota and an international employer with the following words: Mikrobiota, Frauengesundheit and Kinderkrankheiten. Pharmacists work with patients in more than 100 federal states, under the aegis of three production offices in France and Morocco in a research center in France.

“We are frequently at the level of the organization of work with the kinesimetric axis and men, the long experience in the branch of life sciences and pharmacy to benefit from it”, say Cécile Jolivet, Director of Food and Beverage at Biocodex . „We recommend that you make the best choice, we suggest you be patient with innovative products for purchase. We will invest in our Lieferkette, which is so broad that we can do it.”

Während Biocodex weltweit expandiert, werden die Anforderungen et die Lieferkette immer komplexer, weshalb der Bedarf nach einer End-to-End-Orchestrierung stigt. The Kinaxis Maestro platform offers special features for the pharmaceutical industry, including outage management, authority planning and attribute-based planning.

“Patienten, die eine medizinische Behandlung benötigen, müssen ihre Widerstandskraft täglich unter Beweis stellen. When you remove the cover, the handling is correct, and it is widely supported.” say Fabienne Cetre, Executive Vice President EMEA at Kinaxis . “We will frequently be at the level of the procedure to follow with Biocodex. Wirden dafür sorgen, dass sie Störungen in ihrer Lieferkette vorhersehen and managern können. So let’s wait for the patient to take medicine for a rich time.”

Durch die Zusammenarbeit mit Biocodex festigt Kinaxis weiter seine Position in der Life Science-Branche. You are sure that the design of medicines, patient zahllose abhängen, as well as the complex programs of biotechnology, therapy and medical therapy, medical management and preparation of free medicines, enable optimal management.

Read more